Form 13-F position report

ATYR PHARMA INC

Reported by Russell Investments Group Ltd

LIFE CUSIP 002120103 Manager CIK 0001692234

Reported 0 shares, down 25,796 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2017
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 2 Through Q1 2017

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for ATYR PHARMA INC held by Russell Investments Group Ltd.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

38 managers reported ATYR PHARMA INC for Q1 2017.

Managers reporting ATYR PHARMA INC in Q1 2017.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Unchanged 3,557,779 0 < 0.01% $12,452,000 8 qtrs
EcoR1 Capital LLC Added 2,292,659 +1,315,673 2.03% $8,024,000 2 qtrs
Alyeska Investment Group L P Reduced 809,642 -262,466 0.02% $2,834,000 8 qtrs
BlackRock Inc Added 577,171 +557,492 < 0.01% $2,021,000 4 qtrs
Rock Springs Capital Management LP Unchanged 475,000 0 0.1% $1,663,000 8 qtrs
VANGUARD GROUP INC Added 435,324 +78,579 < 0.01% $1,524,000 8 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 112,178 +444 < 0.01% $392,000 7 qtrs
BRIDGEWAY CAPITAL MANAGEMENT LLC Unchanged 102,697 0 < 0.01% $359,000 4 qtrs
DIMENSIONAL FUND ADVISORS LP Added 58,172 +2,800 < 0.01% $204,000 3 qtrs
Bank of America Corporation Reduced 47,708 -4,074 < 0.01% $167,000 8 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2017
Filed
April 26, 2017
Filing type
13F-HR
Position type
Common Stocks

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.